Brief: Pure Biologics Sets Up Doto Medical SPV To Hurry PB103 Commercialisation

Multiqure SA

02/12/2022 07:42

Dec 2 (Reuters) - Pure Biologics SA  PUR1.WA :
    * SETS UP SPV UNDER NAME OF DOTO MEDICAL IN ORDER TO FASTEN
COMMERCIALISATION OF PB103 STRATEGIC PROJECT
    * ALSO SIGNS DEAL WITH M&A CONSULTANT FIRM CLAIRFIELD
PARTNERS TO
ACQUIRE STRATEGIC INVESTOR INTERESTED IN COOPERATION UNDER SPV
    * COMPANY TO MAINTAIN CONTROL OVER SPV UNTIL ITS SALE TO
GLOBAL
MED-TECH DEVICES PRODUCER IN 2024

Source text for Eikon:  ID:nEMbt7qlta 
Further company coverage:  PUR1.WA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))